views

Writing on company which describes itself as “a leading producer and supplier of graphene-based products for use in consumer and industrial markets” Directa Plus (DCTA) at the start of this month with the shares just below 90p I concluded, ahead of the half-year financial detail, still avoid / sell. So what of the now-announced results and the shares more than 12% lower at 76.5p?

views

Writing on company which describes itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) earlier this week, I noted US patents development and “generating considerable interest”, but what about the financials?. So what of now a “pleased to provide… trading update ahead of the announcement of its half year results for the six months to 30 June 2022 on 29 September”?

views

Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) has announced it “has received a Notice of Allowance from the United States Patent and Trademark Office for the grant of a patent covering the Company's G+ embedded polyurethane membrane”, with the offering “generating considerable interest in the US market”. So what of a current 90p share price?

NEWSFLOW

views

Producer and supplier of graphene nanoplatelets-based products Directa Plus (DCTA) has announced 2021 results emphasising “revenue and profitability which have exceeded consensus market expectations” and “a number of exciting opportunities in our targeted markets”. So what of a current 121.5p share price?...

NEWSFLOW

views

Shares in company which describes itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) are currently further higher today to 123p on the back of a “US EPA Authorises Grafysorber for Use in US”-titled announcement. What does this latest here mean?...

views

Having commenced November at a 136p share price, two subsequent announcements have helped shares in Directa Plus (DCTA) up to a current 160p. So what’s this latest news from this ‘graphene nanoplatelets-based products’ company?...

views

Previously writing on graphene nanoplatelets-based products company Directa Plus (DCTA), in June I concluded with the shares at 121.5p, having expressed cash burn concern, I continued to avoid. Today an “Additional Italian Government Covid Recovery Loan” announcement.

views

Self-styled “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) “is pleased to report that this strong revenue growth is continuing in the last two months of the current first half”. What does it mean financially?...